335 related articles for article (PubMed ID: 9457095)
21. Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy.
Behrens GM; Meyer D; Stoll M; Schmidt RE
Immunobiology; 2000 Aug; 202(2):186-93. PubMed ID: 10993293
[TBL] [Abstract][Full Text] [Related]
22. Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection.
Hirsch MS; Steigbigel RT; Staszewski S; McMahon D; Fischl MA; Hirschel B; Squires K; DiNubile MJ; Harvey CM; Chen J; Leavitt RY;
Clin Infect Dis; 2003 Oct; 37(8):1119-24. PubMed ID: 14523778
[TBL] [Abstract][Full Text] [Related]
23. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy.
Carr A; Marriott D; Field A; Vasak E; Cooper DA
Lancet; 1998 Jan; 351(9098):256-61. PubMed ID: 9457096
[TBL] [Abstract][Full Text] [Related]
24. Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy.
Aberg JA; Chin-Hong PV; McCutchan A; Koletar SL; Currier JS
Clin Infect Dis; 2002 Jul; 35(1):E8-E13. PubMed ID: 12060894
[TBL] [Abstract][Full Text] [Related]
25. Prolonged fever due to Mycobacterium avium complex (MAC) disease in advanced HIV infection: a public health concern.
Suwanagool S; Kolladarungkri T; Leelarasamee A; Chuenarom V; Jearanaisilavong J; Chaiprasert A
J Med Assoc Thai; 1998 Nov; 81(11):893-905. PubMed ID: 9803090
[TBL] [Abstract][Full Text] [Related]
26. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
Jacobson MA; Zegans M; Pavan PR; O'Donnell JJ; Sattler F; Rao N; Owens S; Pollard R
Lancet; 1997 May; 349(9063):1443-5. PubMed ID: 9164318
[TBL] [Abstract][Full Text] [Related]
27. Mycobacterium avium complex infection in HIV/AIDS patients.
Corti M; Palmero D
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):351-63. PubMed ID: 18588499
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of an AIDS patient with prolonged Mycobacterium avium bacteremia, high HIV RNA, HBV infection, Kaposi's sarcoma and cytomegalovirus retinitis.
Furukawa Y; Hamada H; Kamikawaji K; Unoki T; Inoue H; Tashiro Y; Okamoto M; Baba M; Hashiguchi T
J Infect Chemother; 2020 Feb; 26(2):279-281. PubMed ID: 31543435
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.
Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Boonyaprawit P
Antivir Ther; 2005; 10(8):911-6. PubMed ID: 16430196
[TBL] [Abstract][Full Text] [Related]
30. Modeling of the change in CD4 lymphocyte counts in patients before and after administration of the human immunodeficiency virus protease inhibitor indinavir.
Stein DS; Drusano GL
Antimicrob Agents Chemother; 1997 Feb; 41(2):449-53. PubMed ID: 9021206
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and factors associated with dry skin in HIV infection: the FRAM study.
Lee D; Benson CA; Lewis CE; Grunfeld C; Scherzer R
AIDS; 2007 Oct; 21(15):2051-7. PubMed ID: 17885295
[TBL] [Abstract][Full Text] [Related]
32. Lamivudine and indinavir/ritonavir maintenance therapy in highly pretreated HIV-infected patients (Vista ANRS 109).
Launay O; Duval X; Dalban C; Descamps D; Peytavin G; Certain A; Mouajjah S; Ralaimazava P; Verdon R; Costagliola D; Clavel F;
Antivir Ther; 2006; 11(7):889-99. PubMed ID: 17302251
[TBL] [Abstract][Full Text] [Related]
33. Mycobacterium avium-complex pericarditis: a case of unmasking immune reconstitution inflammatory syndrome.
Babu TM; Laguio M; Luque AE; Larppanichpoonphol P
Int J STD AIDS; 2014 Feb; 25(2):148-51. PubMed ID: 23970640
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical analysis of cell composition and in situ cytokine expression in HIV- and non-HIV-associated tuberculous lymphadenitis.
Müller H; Krüger S
Immunobiology; 1994 Oct; 191(4-5):354-68. PubMed ID: 7713549
[TBL] [Abstract][Full Text] [Related]
35. Impact of disseminated Mycobacterium avium-complex infection on survival of HIV-infected patients.
Brodt HR; Enzensberger R; Kamps BS; Keul HG; Helm EB
Eur J Med Res; 1997 Mar; 2(3):106-10. PubMed ID: 9113499
[TBL] [Abstract][Full Text] [Related]
36. Mycobacterium avium complex infection-related immune reconstitution inflammatory syndrome of the central nervous system in an HIV-infected patient: case report and review.
Lee YC; Lu CL; Lai CC; Tseng YT; Sun HY; Hung CC
J Microbiol Immunol Infect; 2013 Feb; 46(1):68-72. PubMed ID: 22227308
[TBL] [Abstract][Full Text] [Related]
37. Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD.
Kirk O; Gatell JM; Mocroft A; Pedersen C; Proenca R; Brettle RP; Barton SE; Sudre P; Phillips AN
Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):865-72. PubMed ID: 10988097
[TBL] [Abstract][Full Text] [Related]
38. [Disseminated nontuberculous mycobacterial infections in AIDS patients].
Furrer H; Bodmer T; von Overbeck J
Schweiz Med Wochenschr; 1994 Jan; 124(3):89-96. PubMed ID: 8115842
[TBL] [Abstract][Full Text] [Related]
39. Mycobacterial lymphadenitis associated with the initiation of combination antiretroviral therapy.
Phillips P; Kwiatkowski MB; Copland M; Craib K; Montaner J
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):122-8. PubMed ID: 10048898
[TBL] [Abstract][Full Text] [Related]
40. [Clinical and immuno-virologic efficacy of the expanded access use of protease inhibitors for HIV-1 advanced disease].
Gómez-Vera J; De Alarcón A; Viciana P; Del Nozal Nalda M; Cordero E; Rodríguez-Hernández MJ; Pachón J
An Med Interna; 1999 May; 16(5):218-24. PubMed ID: 10389305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
